$4568 (-1,71 %) together with $AZN (-1 %) is currently developing the drug Datroway (breast cancer). Sales revenues of around € 6 billion are expected by 2030:
What do you think of the share? There is still a dividend and the share price has been down 30% for a year. Irritates me a little. Any opinions?
